Regulatory and Compliance

Regulatory & Compliance Center: Enterprise Medical Device & Robotics Governance Framework

1. Executive Summary & Regulatory Mandate

• Enterprise Scope: Establishes the comprehensive compliance architecture governing all medical hardware, robotics, embedded software, and clinical platforms developed by Rehabwheel Inc. and its subsidiary holding structure.
  
  
• Risk Mitigation Strategy: Designed to eliminate regulatory friction, safeguard patient welfare, satisfy institutional venture capital due diligence requirements, and ensure airtight legal credibility across all operating jurisdictions.
  
  
• Institutional Accountability: Mandates strict adherence to corporate governance standards, ensuring that all research, development, and commercialization activities align with federal and international medical device laws.
  
  

2. Medical Device & Robotics Safety Standards

• Safety Envelope Architecture: Implements rigorous hardware and software safety envelopes, including fail-safe mechanical overrides, real-time telemetry monitoring, and emergency stop protocols for all robotic rehabilitation and cardiovascular therapy systems.
  
  
• QMSR & International Harmonization: Fully aligns with the U.S. Food and Drug Administration's (FDA) Quality Management System Regulation (QMSR), incorporating by reference international standards specific to medical device quality management systems.
  
  
• Core Quality Standards: Operates under strict adherence to ISO 13485 (Medical Devices – Quality Management Systems – Requirements for Regulatory Purposes), ISO 14971 (Application of Risk Management to Medical Devices), and IEC 60601 (Medical Electrical Equipment Safety).
  
  
• Clinical Safety & Verification Protocols: Mandates rigorous pre-clinical testing, engineering validation, and design verification stages prior to any human subject deployment.
  
  
• Hardware Redundancy & Fail-Safe Integration: Incorporates multi-layered electronic and mechanical redundancies to prevent system failure during active patient therapy sessions.
  
  

3. Patient & User Data Privacy Framework

• Data Protection Mandates: Governs the end-to-end collection, transmission, storage, and processing of sensitive patient health information (PHI) and user biometric data.
  
  
• Regulatory Conformity: Strict adherence to data privacy regulations, ensuring complete encryption at rest (AES-256) and in transit (TLS 1.3) across all cloud and edge devices.
  
  
• Consent Architecture: Implements granular, auditable digital consent workflows for all clinical participants and software platform users.
  
  
• Access Control & Anonymization: Enforces strict role-based access protocols and advanced data anonymization techniques to protect individual identity during clinical research and multi-center trials.
  
  

4. Terms of Service & Hardware End-User Agreements

• Liability Limitations: Establishes comprehensive liability protections, disclaimers, and operational limitations for clinical institutions, medical professionals, and end-users operating Rehabwheel hardware.
  
  
• Acceptable Use & Maintenance Protocols: Defines mandatory user training requirements, certified maintenance schedules, and protocols for authorized hardware servicing.
  
  
• Intellectual Property Protection: Protects embedded firmware, proprietary device interfaces, and user-facing software from reverse engineering, unauthorized modification, or illicit distribution.
  
  
• Warranties & Operational Disclaimers: Explicitly details the operational boundaries, warranty limitations, and compliance responsibilities required of third-party clinical partners utilizing the equipment.
  
  

5. Quality Management & Post-Market Surveillance

• Continuous Audit Trails: Establishes automated logging systems to track device performance telemetry, software updates, and hardware diagnostics in real-time.
  
  
• Adverse Event Reporting: Implements a formalized protocol for documenting, investigating, and reporting any device malfunctions or safety anomalies to internal clinical advisors and regulatory bodies.
  
  
• Continuous Improvement Lifecycle: Integrates feedback loops from clinical trials and partner facilities directly into engineering and R&D pipelines for rapid quality enhancement.
  
  
• Recall & Corrective Action Procedures: Outlines strict operational protocols for executing immediate corrective and preventive actions (CAPA) should any systemic safety or regulatory variance be identified.
  
  

6. Clinical Trial Governance & Human Subjects Protection

• Institutional Review Board (IRB) Compliance: Mandates that all clinical validation, pilot studies, and pivotal trials receive formal IRB approval and adhere strictly to Good Clinical Practice (GCP) guidelines.
  
  
• Informed Consent Lifecycle: Ensures that human subjects are fully briefed on potential risks, mechanical operations, and data usage rights, maintaining transparent and documented consent records.
  
  
• Adverse Event Monitoring Boards (DSMB): Establishes independent data safety monitoring boards to oversee ongoing clinical trials, evaluate patient safety metrics, and recommend trial continuation or modification based on empirical outcomes.
  
  

7. Intellectual Property & Patent Integration

• Proprietary Asset Security: Directly links compliance frameworks with corporate patent portfolios, including the LegMaker technology and related utility patents, to prevent unauthorized disclosure during regulatory filings.
  
  
• Open Source & Third-Party Audit: Restricts the integration of unvetted open-source codebases within safety-critical robotic control systems to protect core intellectual property and maintain regulatory compliance.
  
  
• Inventor Attestation: Requires all engineering and clinical research personnel to maintain active compliance with corporate Proprietary Information and Inventions Agreements (PIIA).
  
  

8. Cybersecurity & Edge-Computing Infrastructure

• Zero-Trust Architecture: Implements a strict zero-trust cybersecurity framework across all networked medical devices, cloud servers, and internal developer environments.
  
  
• Firmware Integrity Verification: Utilizes cryptographic hashing and secure boot protocols to ensure that all over-the-air (OTA) firmware updates executed on Rehabwheel hardware are verified and tamper-proof.
  
  
• Vulnerability Management & Pen Testing: Mandates regular third-party penetration testing, vulnerability scanning, and rapid patch deployment cycles to counter emerging digital threats.
  
  

9. Environmental, Health & Safety (EHS) Standards

• Manufacturing Facility Compliance: Enforces stringent EHS protocols across all assembly, prototyping, and hardware manufacturing facilities operated by Rehabwheel Inc. and its subsidiaries.
  
  
• Hazardous Materials Management: Regulates the safe handling, storage, and disposal of specialized electronic components, batteries, and materials utilized in advanced medical robotics construction.
  
  
• Workplace Safety Protocols: Implements mandatory safety training, personal protective equipment (PPE) standards, and ergonomic guidelines for all engineering and assembly personnel.
  
  

10. Audit, Enforcement & Continuous Governance Review

• Internal Compliance Audits: Establishes a scheduled cadence of internal audits led by designated compliance officers to review operational adherence across all departments and subsidiaries.
  
  
• Regulatory Update Tracking: Maintains a dedicated legal tracking mechanism to continuously monitor evolving federal, state, and international medical device regulations, ensuring proactive policy adaptation.
  
  
• Executive Oversight & Accountability: Requires quarterly compliance reporting directly to the Chief Executive Officer (Nikita Chizhov), executive leadership, and the Board of Directors to ensure total institutional alignment and accountability.